Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

This study has been completed.
Sponsor:
Information provided by:
Bayhill Therapeutics
ClinicalTrials.gov Identifier:
NCT00103974
First received: February 17, 2005
Last updated: April 4, 2008
Last verified: February 2008